Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Carol Brosgart
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Living Beings
Physiology
Procedures
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
11
Xiong, Shelly
8
Fry, John
7
Westland, Christopher
6
Gibbs, Craig
6
Delaney, William
6
Heathcote, Jenny
6
Marcellin, Patrick
5
Goodman, Zachary
5
Lim, Seng Gee
5
Yang, Huiling
5
Wulfsohn, Michael
4
Tassopoulos, Nicolaos
4
Schiff, Eugene
4
Hadziyannis, Stephanos
4
Hadziyannis, Stephanos
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Carol Brosgart (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Kim W Ray; Terrault Norah A; Pedersen Rachel A; Therneau Terry M; Edwards Erick; Hindman Andrew A; Brosgart Carol L
Trends in waiting list registration for liver transplantation for viral hepatitis in the United States.
Gastroenterology 2009;137(5):1680-6.
-
2008: Sung Joseph J Y; Lai Jak-Yiu; Zeuzem Stefan; Chow Wan Chen; Heathcote E Jenny; Perrillo Robert P; Brosgart Carol L; Woessner Mary A; Scott Susan A; Gray D Fraser; Gardner Stephen D
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B.
Journal of hepatology 2008;48(5):728-35.
-
2008: Cooksley Helen; Chokshi Shilpa; Maayan Yafit; Wedemeyer Heiner; Andreone Pietro; Gilson Richard; Warnes Thomas; Paganin Simona; Zoulim Fabien; Frederick David; Neumann Avidan U; Brosgart Carol L; Naoumov Nikolai V
Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.
Antimicrobial agents and chemotherapy 2008;52(1):312-20.
-
2007: Lim S G; Marcellin P; Tassopoulos N; Hadziyannis S; Chang T T; Tong M; Sievert W; Hu P; Arterburn S; Brosgart C L;
Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B.
Alimentary pharmacology & therapeutics 2007;26(10):1419-28.
-
2007: Schiff Eugene; Lai Ching-Lung; Hadziyannis Stephanos; Neuhaus Peter; Terrault Norah; Colombo Massimo; Tillmann Hans; Samuel Didier; Zeuzem Stefan; Villeneuve Jean-Pierre; Arterburn Sarah; Borroto-Esoda Katyna; Brosgart Carol; Chuck Steven;
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(3):349-60.
-
2006: Hadziyannis Stephanos J; Tassopoulos Nicolaos C; Heathcote E Jenny; Chang Ting-Tsung; Kitis George; Rizzetto Mario; Marcellin Patrick; Lim Seng Gee; Goodman Zachary; Ma Jia; Brosgart Carol L; Borroto-Esoda Katyna; Arterburn Sarah; Chuck Steven L;
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.
Gastroenterology 2006;131(6):1743-51.
-
2006: Peters Marion G; Andersen Janet; Lynch Patrick; Liu Tun; Alston-Smith Beverly; Brosgart Carol L; Jacobson Jeffrey M; Johnson Victoria A; Pollard Richard B; Rooney James F; Sherman Kenneth E; Swindells Susan; Polsky Bruce;
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.
Hepatology (Baltimore, Md.) 2006;44(5):1110-6.
-
2006: Wursthorn Karsten; Lutgehetmann Marc; Dandri Maura; Volz Tassilo; Buggisch Peter; Zollner Bernhard; Longerich Thomas; Schirmacher Peter; Metzler Frauke; Zankel Myrga; Fischer Conrad; Currie Graeme; Brosgart Carol; Petersen Joerg
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B.
Hepatology (Baltimore, Md.) 2006;44(3):675-84.
-
2006: Benhamou Yves; Thibault Vincent; Vig Pamela; Calvez Vincent; Marcelin Anne-Genevieve; Fievet Marie-Hélène; Currie Graeme; Chang Chuy G; Biao Lu; Xiong Shelly; Brosgart Carol; Poynard Thierry
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.
Journal of hepatology 2006;44(1):62-7.
-
2005: Fontaine Hélène; Vallet-Pichard Anaïs; Chaix Marie-Laure; Currie Graham; Serpaggi Jeanne; Verkarre Virginie; Varaut Anne; Morales Eugenia; Nalpas Bertrand; Brosgart Carol; Pol Stanislas
Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency.
Transplantation 2005;80(8):1086-92.
-
2005: Hadziyannis Stephanos J; Tassopoulos Nicolaos C; Heathcote E Jenny; Chang Ting-Tsung; Kitis George; Rizzetto Mario; Marcellin Patrick; Lim Seng Gee; Goodman Zachary; Ma Jia; Arterburn Sarah; Xiong Shelly; Currie Graeme; Brosgart Carol L;
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
The New England journal of medicine 2005;352(26):2673-81.
-
2005: Westland C E; Yang H; Delaney W E; Wulfsohn M; Lama N; Gibbs C S; Miller M D; Fry J; Brosgart C L; Schiff E R; Xiong S
Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients.
Journal of viral hepatitis 2005;12(1):67-73.
-
2004: Izzedine Hassane; Hulot Jean Sebastien; Launay-Vacher Vincent; Marcellini Patrick; Hadziyannis Stephanos J; Currie Graham; Brosgart Carol L; Westland Chris; Arterbrun Sarah; Deray Gilbert;
Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies.
Kidney international 2004;66(3):1153-8.
-
2004: Werle-Lapostolle Bettina; Bowden Scott; Locarnini Stephen; Wursthorn Karsten; Petersen Jorg; Lau George; Trepo Christian; Marcellin Patrick; Goodman Zachary; Delaney William E; Xiong Shelly; Brosgart Carol L; Chen Shan-Shan; Gibbs Craig S; Zoulim Fabien
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.
Gastroenterology 2004;126(7):1750-8.
-
2004: Hannon Heidi; Bagnis Corinne Isnard; Benhamou Yves; Beaufils Hélène; Sullivan Mark; Brosgart Carol; Izzedine Hassan; Poynard Thierry; Deray Gilbert
The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(2):386-90.
-
2004: Peters Marion G; Hann Hw H w; Martin Paul; Heathcote E Jenny; Buggisch P; Rubin R; Bourliere M; Kowdley K; Trepo C; Gray Df D f; Sullivan M; Kleber K; Ebrahimi R; Xiong S; Brosgart Carol L
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
Gastroenterology 2004;126(1):91-101.
-
2004: Perrillo Robert; Hann Hie-Won; Mutimer David; Willems Bernard; Leung Nancy; Lee William M; Moorat Alison; Gardner Stephen; Woessner Mary; Bourne Eric; Brosgart Carol L; Schiff Eugene
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.
Gastroenterology 2004;126(1):81-90.
-
2003: Schiff Eugene R; Lai Ching-Lung; Hadziyannis Stefanos; Neuhaus Peter; Terrault Norah; Colombo Massimo; Tillmann Hans L; Samuel Didier; Zeuzem Stefan; Lilly Leslie; Rendina Maria; Villeneuve Jean-Pierre; Lama Nicole; James Craig; Wulfsohn Michael S; Namini Hamid; Westland Christopher; Xiong Shelly; Choy Gavin S; Van Doren Sally; Fry John; Brosgart Carol L;
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.
Hepatology (Baltimore, Md.) 2003;38(6):1419-27.
-
2003: Villeneuve Jean-Pierre; Durantel David; Durantel Sandra; Westland Christopher; Xiong Shelly; Brosgart Carol L; Gibbs Craig S; Parvaz Parviz; Werle Bettina; Trépo Christian; Zoulim Fabien
Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.
Journal of hepatology 2003;39(6):1085-9.
-
2003: Angus Peter; Vaughan Rhys; Xiong Shelly; Yang Huiling; Delaney William; Gibbs Craig; Brosgart Carol; Colledge Danielle; Edwards Rosalind; Ayres Anna; Bartholomeusz Angeline; Locarnini Stephen
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.
Gastroenterology 2003;125(2):292-7.
-
2003: Westland Chris; Delaney William; Yang Huiling; Chen Shan-Shan; Marcellin Patrick; Hadziyannis Stephanos; Gish Robert; Fry John; Brosgart Carol; Gibbs Craig; Miller Michael; Xiong Shelly
Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1.
Gastroenterology 2003;125(1):107-16.
-
2003: Westland Christopher E; Yang Huiling; Delaney William E; Gibbs Craig S; Miller Michael D; Wulfsohn Michael; Fry John; Brosgart Carol L; Xiong Shelly;
Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B.
Hepatology (Baltimore, Md.) 2003;38(1):96-103.
-
2003: Marcellin Patrick; Chang Ting-Tsung; Lim Seng Gee; Tong Myron J; Sievert William; Shiffman Mitchell L; Jeffers Lennox; Goodman Zachary; Wulfsohn Michael S; Xiong Shelly; Fry John; Brosgart Carol L;
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.
The New England journal of medicine 2003;348(9):808-16.
-
2003: Hadziyannis Stephanos J; Tassopoulos Nicolaos C; Heathcote E Jenny; Chang Ting-Tsung; Kitis George; Rizzetto Mario; Marcellin Patrick; Lim Seng Gee; Goodman Zachary; Wulfsohn Michael S; Xiong Shelly; Fry John; Brosgart Carol L;
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.
The New England journal of medicine 2003;348(9):800-7.
-
2002: Yang Huiling; Westland Christopher E; Delaney William E; Heathcote Elizabeth J; Ho Victoria; Fry John; Brosgart Carol; Gibbs Craig S; Miller Michael D; Xiong Shelly
Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks.
Hepatology (Baltimore, Md.) 2002;36(2):464-73.
-
2002: Hammer Scott M; Vaida Florin; Bennett Kara K; Holohan Mary K; Sheiner Lewis; Eron Joseph J; Wheat Lawrence Joseph; Mitsuyasu Ronald T; Gulick Roy M; Valentine Fred T; Aberg Judith A; Rogers Michael D; Karol Cheryl N; Saah Alfred J; Lewis Ronald H; Bessen Laura J; Brosgart Carol; DeGruttola Victor; Mellors John W;
Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.
JAMA : the journal of the American Medical Association 2002;288(2):169-80.
-
2002: Falloon Judith; Ait-Khaled Mounir; Thomas Deborah A; Brosgart Carol L; Eron Jr Joseph J; Feinberg Judith; Flanigan Timothy P; Hammer Scott M; Kraus Peter W; Murphy Robert; Torres Ramon; Masur Henry;
HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients.
AIDS (London, England) 2002;16(3):387-96.
-
2001: Benhamou Y; Bochet M; Thibault V; Calvez V; Fievet M H; Vig P; Gibbs C S; Brosgart C; Fry J; Namini H; Katlama C; Poynard T
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.
Lancet 2001;358(9283):718-23.
-
2000: Shulman N S; Zolopa A R; Passaro D J; Murlidharan U; Israelski D M; Brosgart C L; Miller M D; Van Doren S; Shafer R W; Katzenstein D A
Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response.
Journal of acquired immune deficiency syndromes (1999) 2000;23(3):221-6.
Sign-in to see more
